CalciMedica Net Income from 2010 to 2026

CALC Stock   5.85  0.52  9.76%   
CalciMedica Common's Net Loss is increasing over the years with slightly volatile fluctuation. Net Loss is expected to dwindle to about -16.5 M. During the period from 2010 to 2026 CalciMedica Common Net Loss annual values regression line had coefficient of variation of (30.53) and r-squared of  0.21. View All Fundamentals
 
Net Loss  
First Reported
2019-09-30
Previous Quarter
-6 M
Current Value
-7.8 M
Quarterly Volatility
4.1 M
 
Covid
Check CalciMedica Common financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CalciMedica Common's main balance sheet or income statement drivers, such as Depreciation And Amortization of 49.6 K, Selling General Administrative of 12 M or Other Operating Expenses of 23.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.61. CalciMedica financial statements analysis is a perfect complement when working with CalciMedica Common Valuation or Volatility modules.
  
Build AI portfolio with CalciMedica Stock
Check out the analysis of CalciMedica Common Correlation against competitors.

Latest CalciMedica Common's Net Income Growth Pattern

Below is the plot of the Net Income of CalciMedica Common Stock over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in CalciMedica Common Stock financial statement analysis. It represents the amount of money remaining after all of CalciMedica Common Stock operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is CalciMedica Common's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CalciMedica Common's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (13.7 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

CalciMedica Net Income Regression Statistics

Arithmetic Mean(26,115,868)
Coefficient Of Variation(30.53)
Mean Deviation5,957,849
Median(28,378,000)
Standard Deviation7,973,288
Sample Variance63.6T
Range29.2M
R-Value0.46
Mean Square Error53.7T
R-Squared0.21
Significance0.07
Slope720,926
Total Sum of Squares1017.2T

CalciMedica Net Income History

2026-16.5 M
2025-15.8 M
2024-13.7 M
2023-34.4 M
2022-7.8 M
2021-35.8 M
2020-27.5 M

Other Fundumenentals of CalciMedica Common Stock

CalciMedica Common Net Income component correlations

About CalciMedica Common Financial Statements

CalciMedica Common stakeholders use historical fundamental indicators, such as CalciMedica Common's Net Income, to determine how well the company is positioned to perform in the future. Although CalciMedica Common investors may analyze each financial statement separately, they are all interrelated. For example, changes in CalciMedica Common's assets and liabilities are reflected in the revenues and expenses on CalciMedica Common's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CalciMedica Common Stock. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-15.8 M-16.5 M
Net Loss-15.8 M-16.5 M
Net Loss-13.1 M-13.7 M
Net Loss(1.10)(1.15)
Net Income Per E B T 4.10  3.64 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CalciMedica Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica Common Stock Stock:
Check out the analysis of CalciMedica Common Correlation against competitors.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica Common. If investors know CalciMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.62)
Return On Assets
(1.00)
Return On Equity
(5.26)
The market value of CalciMedica Common Stock is measured differently than its book value, which is the value of CalciMedica that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica Common's market value can be influenced by many factors that don't directly affect CalciMedica Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CalciMedica Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.